Published in Interdiscip Perspect Infect Dis on March 29, 2009
Patterns of prokaryotic lateral gene transfers affecting parasitic microbial eukaryotes. Genome Biol (2013) 1.17
Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr (2010) 0.95
Role of probiotics in urogenital healthcare. J Midlife Health (2011) 0.92
Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman. BMC Microbiol (2016) 0.87
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric (2015) 0.84
The transcriptional stress response of Candida albicans to weak organic acids. G3 (Bethesda) (2015) 0.82
Maternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review. Adv Neonatal Care (2015) 0.81
Probiotics to counteract biofilm-associated infections: promising and conflicting data. Int J Oral Sci (2014) 0.81
Perceptions about probiotic yogurt for health and nutrition in the context of HIV/AIDS in Mwanza, Tanzania. J Health Popul Nutr (2012) 0.79
Molecular analysis and clinical significance of Lactobacillus spp. recovered from clinical specimens presumptively associated with disease. J Clin Microbiol (2013) 0.78
MIG1 Regulates Resistance of Candida albicans against the Fungistatic Effect of Weak Organic Acids. Eukaryot Cell (2015) 0.78
The Sialidase NanS Enhances Non-TcsL Mediated Cytotoxicity of Clostridium sordellii. Toxins (Basel) (2016) 0.76
The female urinary microbiota, urinary health and common urinary disorders. Ann Transl Med (2017) 0.75
Effects of processing and storage on Pediococcus pentosaceus SB83 in vaginal formulations: lyophilized powder and tablets. Biomed Res Int (2013) 0.75
Probiotics for vaginal health in South Africa: what is on retailers' shelves? BMC Womens Health (2017) 0.75
Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microb Ecol Health Dis (2017) 0.75
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med (2005) 11.23
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J (2007) 4.36
Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol (2000) 4.26
The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis (1999) 3.95
Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67
Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med (2007) 3.54
Vulvovaginal candidosis. Lancet (2007) 3.50
Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A (2007) 3.32
Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis (1990) 3.19
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol (2007) 2.88
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol (2002) 2.67
Adherent biofilms in bacterial vaginosis. Obstet Gynecol (2005) 2.31
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis (2005) 2.21
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol (2003) 2.06
Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG (2002) 2.01
Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis (1998) 1.92
Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J Infect Dis (2002) 1.91
Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol (2003) 1.89
The microbiology of bacterial vaginosis. Am J Obstet Gynecol (1993) 1.79
Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol (1987) 1.77
Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol (2001) 1.73
Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis (2003) 1.72
Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol (2004) 1.72
Escherichia coli bacteriuria and contraceptive method. JAMA (1991) 1.71
Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl Environ Microbiol (1996) 1.71
Defense factors of vaginal lactobacilli. Am J Obstet Gynecol (2001) 1.68
Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun (1998) 1.65
Effect on urogenital flora of antibiotic therapy for urinary tract infection. Scand J Infect Dis (1990) 1.60
Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation (2002) 1.57
Hidden pathogens uncovered: metagenomic analysis of urinary tract infections. Andrologia (2008) 1.57
Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol (2001) 1.52
Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect (2006) 1.52
Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol (2007) 1.51
Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis (2003) 1.44
Probiotics for mother and child. J Clin Gastroenterol (2004) 1.44
Lactobacillus strains and vaginal ecology. JAMA (2002) 1.41
Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol (1998) 1.36
Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol (2004) 1.35
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect (2006) 1.31
Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods. Am J Obstet Gynecol (2005) 1.28
Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol (1992) 1.28
Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis (2000) 1.27
Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol (2005) 1.25
Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiol Lett (2000) 1.24
G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol (2006) 1.23
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol (2006) 1.23
Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand (2002) 1.21
Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis (1999) 1.17
Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol (2007) 1.16
Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet Gynecol Scand (1993) 1.15
Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces (2006) 1.14
Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis (2008) 1.13
Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl Environ Microbiol (2008) 1.12
Relationship between hydrogen peroxide-producing strains of lactobacilli and vaginosis-associated bacterial species in pregnant women. Eur J Clin Microbiol Infect Dis (1997) 1.12
Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis (1992) 1.11
Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol (2005) 1.10
BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol (2003) 1.07
Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr (2001) 1.04
Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis (2004) 1.03
Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet (1994) 1.02
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis (2003) 1.01
The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol (2005) 1.00
Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med (1996) 0.99
Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol (2002) 0.99
An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin Infect Dis (2007) 0.99
Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro. Appl Environ Microbiol (1996) 0.99
Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol (2004) 0.98
Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynecol Reprod Biol (2003) 0.98
Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol (2007) 0.98
Recurrent urethritis in women. Can Med Assoc J (1973) 0.96
A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol (2005) 0.94
Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology (2006) 0.93
Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol (2008) 0.92
Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility. Am J Obstet Gynecol (2001) 0.92
Vaginal colonization by bacteria and yeast. Am J Obstet Gynecol (1988) 0.91
Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis. Eur J Obstet Gynecol Reprod Biol (2004) 0.90
Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt) (2006) 0.87
Organisms associated with bacterial vaginosis in Nigerian women as determined by PCR-DGGE and 16S rRNA gene sequence. Afr Health Sci (2007) 0.86
Bacterial vaginosis is not a simple ecological disorder. Gynecol Obstet Invest (1989) 0.86
What's new in management of sexually transmitted infections? Canadian Guidelines on Sexually Transmitted Infections, 2006 Edition. Can Fam Physician (2007) 0.84
Urinary tract infections in pregnant women with bacterial vaginosis. J Obstet Gynaecol (2007) 0.84
Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes. Microbes Infect (2008) 0.83
Sexually transmitted infections in adolescent women. Clin Obstet Gynecol (2008) 0.83
Probiotic prophylaxis in predicted severe acute pancreatitis. Lancet (2008) 0.80
Drug resistance amongst uropathogens isolated from women in a suburban population: laboratory findings over 7 years. Can J Urol (1997) 0.80
Microbiome profiling by illumina sequencing of combinatorial sequence-tagged PCR products. PLoS One (2010) 3.51
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J Infect Dis (2002) 1.91
Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol (2003) 1.89
Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem (2005) 1.77
Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis (2006) 1.54
Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect (2006) 1.52
N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists. J Med Chem (2009) 1.52
Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol (2005) 1.50
Lactobacillus strains and vaginal ecology. JAMA (2002) 1.41
Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol (2004) 1.35
Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol (2008) 1.33
Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect (2006) 1.31
At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A (2010) 1.30
Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek (2006) 1.28
Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1.28
Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. Bioorg Med Chem (2005) 1.26
A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol (2012) 1.25
Microbiota of human breast tissue. Appl Environ Microbiol (2014) 1.24
G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol (2006) 1.23
Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol (2010) 1.22
Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol (2003) 1.16
Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother (2010) 1.15
Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One (2011) 1.15
Bioremediation and tolerance of humans to heavy metals through microbial processes: a potential role for probiotics? Appl Environ Microbiol (2012) 1.15
Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces (2006) 1.14
High throughput sequencing methods and analysis for microbiome research. J Microbiol Methods (2013) 1.14
Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl Environ Microbiol (2008) 1.12
The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep (2013) 1.11
Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol (2005) 1.10
Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol (2009) 1.09
Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol (2002) 1.06
Synthesis and characterization of selective dopamine D2 receptor antagonists. Bioorg Med Chem (2005) 1.06
Urinary tract biomaterials. J Urol (2004) 1.05
No causal link between obesity and probiotics. Nat Rev Microbiol (2009) 1.05
Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR. Bioorg Med Chem Lett (2006) 1.04
Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes (2011) 1.04
Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol (2012) 1.03
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
FAO Technical meeting on prebiotics. J Clin Gastroenterol (2008) 1.01
Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces (2011) 1.00
Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J Infect Dis (2002) 1.00
Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol (2012) 0.99
ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-Seq. PLoS One (2013) 0.99
Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 0.98
Complexity of vaginal microflora as analyzed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis. Infect Dis Obstet Gynecol (2005) 0.97
Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal (2004) 0.97
Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int Rev Immunol (2010) 0.97
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov Disord (2010) 0.96
A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit (2011) 0.95
Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am J Obstet Gynecol (2011) 0.95
Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol Immunol (2009) 0.95
Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynaecol Obstet (2010) 0.95
Importance of vaginal microbes in reproductive health. Reprod Sci (2012) 0.95
Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement. Immunobiology (2011) 0.94
PCR-based identification of eight Lactobacillus species and 18 hr-HPV genotypes in fixed cervical samples of South African women at risk of HIV and BV. Diagn Cytopathol (2011) 0.94
African traditional fermented foods and probiotics. J Med Food (2009) 0.94
Adhesion forces and coaggregation between vaginal staphylococci and lactobacilli. PLoS One (2012) 0.94
Breast, milk and microbes: a complex relationship that does not end with lactation. Womens Health (Lond Engl) (2012) 0.94
Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology (2006) 0.93
Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor. Am J Obstet Gynecol (2009) 0.93
Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14. Cell Microbiol (2006) 0.93
Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol (2008) 0.92
Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model. J Urol (2006) 0.92
Splenic hamartoma: immunohistochemical and ultrastructural profile of two cases. Int J Surg Pathol (2005) 0.92
Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study. Synapse (2011) 0.92
The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes (2014) 0.92
Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis. Eur J Obstet Gynecol Reprod Biol (2004) 0.90
Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report. Gut Microbes (2011) 0.89
Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients (2011) 0.88
Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother (2014) 0.87
Differences in the haematological profile of healthy 70 year old men and women: normal ranges with confirmatory factor analysis. BMC Blood Disord (2010) 0.87
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Bioorg Med Chem (2010) 0.87
Prediction of preterm birth in symptomatic women using decision tree modeling for biomarkers. Am J Obstet Gynecol (2008) 0.87
A targeted, conventional assay, emergency department HIV testing program integrated with existing clinical procedures. Ann Emerg Med (2011) 0.87
Organisms associated with bacterial vaginosis in Nigerian women as determined by PCR-DGGE and 16S rRNA gene sequence. Afr Health Sci (2007) 0.86
HPV Type Distribution and Cervical Cytology among HIV-Positive Tanzanian and South African Women. ISRN Obstet Gynecol (2012) 0.86
Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol (2013) 0.85
Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands. J Med Chem (2011) 0.85
Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14. Appl Environ Microbiol (2008) 0.85
Micronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression. Nutrients (2010) 0.85
Novel application of GI electrical stimulation in Roux stasis syndrome (with video). Gastrointest Endosc (2011) 0.84
Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4. BMC Microbiol (2012) 0.83
Lactobacillus rhamnosus GR-1 stimulates colony-stimulating factor 3 (granulocyte) (CSF3) output in placental trophoblast cells in a fetal sex-dependent manner. Biol Reprod (2010) 0.83
Safety of lactobacillus strains as probiotic agents. Clin Infect Dis (2002) 0.83
Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes. Microbes Infect (2008) 0.83
Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound. Bioorg Med Chem (2011) 0.82
Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS One (2013) 0.82
Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol. J Med Chem (2008) 0.82
In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens. J Endourol (2006) 0.82
Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity. MBio (2015) 0.82
Lactobacillus rhamnosus GR-1-induced IL-10 production in human placental trophoblast cells involves activation of JAK/STAT and MAPK pathways. Reprod Sci (2010) 0.81
Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease. Reprod Sci (2012) 0.81
Adhesion of Lactobacillus iners AB-1 to human fibronectin: a key mediator for persistence in the vagina? Reprod Sci (2012) 0.81
Genome sequence of Lactobacillus pentosus KCA1: vaginal isolate from a healthy premenopausal woman. PLoS One (2013) 0.80
Probiotic prophylaxis in predicted severe acute pancreatitis. Lancet (2008) 0.80
Development and pilot evaluation of a novel probiotic mixture for the management of seasonal allergic rhinitis. Can J Microbiol (2010) 0.80
In vitro evaluation of the viability of vaginal cells (VK2/E6E7) and probiotic Lactobacillus species in lemon juice. Sex Health (2009) 0.80